应用DNA科学宣布提供6.5百万美元用于治疗DNA开发和一般需要。 Applied DNA Sciences announces a $6.5m offering for Therapeutic DNA development and general needs.

Applied DNA Sciences 宣布进行注册直接发行和私募配售，旨在筹集约 650 万美元。 Applied DNA Sciences announced a registered direct offering and private placement aimed at raising approximately $6.5 million. 此次发行包括 20,312,500 股普通股，每股价格为 0.32 美元，以及 C 系列和 D 系列认股权证。 The offering includes 20,312,500 shares of common stock priced at $0.32 each, along with Series C and D warrants. 收益将支持治疗DNA生产服务的发展,并满足公司的一般需要。 Proceeds will support the development of Therapeutic DNA Production Services and cover general corporate needs. 预计,在习惯条件尚未确定之前,2024年10月31日,这项提议将终止。 The offering is expected to close by October 31, 2024, pending customary conditions.